title: Dalteparin in critically ill patients.
authors.forename: Maureen A
authors.initials: MA
authors.lastname: Smythe
authors.forename: John M
authors.initials: JM
authors.lastname: Koerber
mesh_terms: D000925:Anticoagulants / Q000009:adverse effects* / Q000627:therapeutic use; D016638:Critical Illness / Q000628:therapy; D017985:Dalteparin / Q000009:adverse effects* / Q000627:therapeutic use; D006493:Heparin / Q000009:adverse effects* / Q000627:therapeutic use; D006801:Humans; D013921:Thrombocytopenia / Q000139:chemically induced*; D020246:Venous Thrombosis / Q000517:prevention & control*
chemical_list: D000925:Anticoagulants; D006493:Heparin; D017985:Dalteparin